Enhanced Bioavailability of Pethidine and Pentazocine in Patients with Cirrhosis of the Liver*
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
INDOCYANINE GREEN: OBSERVATIONS ON ITS PHYSICAL PROPERTIES, PLASMA DECAY, AND HEPATIC EXTRACTION*
1960 • 926 citations
The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.
1961 • 776 citations
Altered Hepatic Blood Flow and Drug Disposition1
1976 • 209 citations
First-pass effect of nalorphine in rats.
1977 • 151 citations
Morphine tolerance in hepatic cirrhosis
1961 • 137 citations
Rapid gas-liquid chromatographic estimation of antipyrine in plasma
1973 • 135 citations
Enhanced Bioavailability and Decreased Clearance of Analgesics in Patients with Cirrhosis
1979 • 133 citations
Mechanism for reduced drug clearance in patients with cirrhosis
1978 • 128 citations
Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration
1971 • 66 citations
Bioavailability and first‐pass metabolism of oral pentazocine in man
1977 • 64 citations
Systemic availability of orally administered meperidine
1976 • 44 citations
Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole.
1978 • 42 citations
Gas chromatographic analysis of pentazocine
1978 • 16 citations
Pethidine and Liver Damage
1952 • 15 citations
Title for Anaesthetists
1972 • 11 citations
Bioavailabllity of lidocaine in normal volunteers and cirrhotic patients
1978 • 7 citations